AI assistant
Sending…
DAVITA INC. — Director's Dealing 2016
May 27, 2016
30643_dirs_2016-05-26_5fedd209-0916-492b-8256-4cfa48af3ae3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-25
Reporting Person: Arway Pamela M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-25 | Common Stock | M | 24000 | $42.465 | Acquired | 36394 | Direct |
| 2016-05-25 | Common Stock | F | 13176 | $77.35 | Disposed | 23218 | Direct |
| 2016-05-25 | Common Stock | S | 10824 | $77.1633 | Disposed | 12394 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-25 | Stock Appreciation Rights | $42.465 | M | 24000 | Disposed | 2017-06-11 | Common Stock (24000) | Direct |
Footnotes
F1: Represents the weighted average sale price of $77.1633. The range of prices for the sale of these shares was $76.87-$77.50, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: The Stock Appreciation Rights were granted on 6/11/2012. 100% vested on 6/11/2013.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25